PreveCeutical targets up to $600,000 in C$0.03-per-unit private placement

• PreveCeutical launched a non-brokered private placement of up to 20,000,000 units at $0.03 per unit to raise up to $600,000.
• Each unit includes 1 common share, 0.5 warrant; each whole warrant exercisable at $0.06 for two years.
• Warrant expiry can be accelerated if the CSE closing price is $0.11 or higher for 10 straight trading days.
• Proceeds earmarked for short-loan repayments, professional fees, patents, further studies, and general working capital.
• Securities will be unregistered under the U.S. Securities Act; resale restrictions include a four-month-and-one-day hold period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Preveceutical Medical Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609281700NEWSFILECNPR____20260928_316382_1) on September 28, 2026, and is solely responsible for the information contained therein.